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a b s t r a c t
Ethnopharmacological relevance: Muntingia calabura L. (Muntingiaceae) is locally known as kerukup siam.
Its leaves, ﬂowers, barks and roots have been used traditionally in East Asia and South America to treat
various diseases including ulcer-related diseases. The present study aimed to investigate the mechanism
(s) of gastroprotective effect of methanol extract of Muntingia calabura leaves (MEMC) using the pylorus
ligation induced gastric ulceration in rats.
Materials and methods: Five groups of rats (n¼6) were administered orally once daily for 7 days with
8% Tween 80 (negative control), 100 mg/kg ranitidine (positive control), or MEMC (100, 250 or 500 mg/kg),
followed by the ulcer induction via ligation of the pyloric part of the rat’s stomach. This was followed by the
macroscopic analysis of the stomach, evaluation of gastric content parameters, and quantiﬁcation of mucus
content. The antioxidant (measured using the superoxide anion and 2,2-diphenyl-1-picrylhydrazyl (DPPH)-
radical scavenging, oxygen radical absorbance capacity (ORAC) and total phenolic content (TPC) assays),
anti-inﬂammatory (evaluated using the in vitro lipoxygenase and xanthine oxidase assays), phytocon-
stituents and HPLC analysis of MEMC were also carried out.
Results: The MEMC signiﬁcantly (po0.05) reduced gastric lesion in this model. Furthermore, the extract
also signiﬁcantly (po0.01) reduced the volume of gastric content whereas the total acidity was
signiﬁcantly (po0.05) reduced in the doses of 100 and 500 mg/kg MEMC. Moreover, the mucus content
increased signiﬁcantly (po0.01) in MEMC-treated rats. The extract also showed high antioxidant and anti-
inﬂammatory activities in all assays tested, and demonstrated the presence of high tannins and saponins
followed by ﬂavonoids.
Conclusion: The MEMC exerted gastroprotective effect via several mechanisms including the anti-secretory,
antioxidant and anti-inﬂammatory activities. These activities could be attributed to the presence of tannins,
saponins and ﬂavonoids (e.g. rutin, quercitrin, ﬁsetin and dihydroquercetin).
&2013 The Authors. Published by Elsevier Ireland Ltd.
1. Introduction
Peptic ulcers have become one of the major human illness
affecting nearly 8–10% of the global population (Calam and Baron,
2001), and of these number, 5% suffer from gastric ulcers
(Bandyopadhyay et al., 2001). Diverse factors such as alcohol
consumption, a stressful lifestyle, use of steroidal and non-steroidal
anti-inﬂammatory drugs (NSAIDs) and drugs which stimulate gastric
acid and pepsin secretion, Helicobacter pylori infections and smoking
contribute to the pathogenesis of gastric ulcers (Rang et al., 2012).
An imbalance between the aggressive factors such as acid and pepsin
secretion, Helicobacter pylori, reﬂuxed bile, release of leukotrienes
and reactive oxygen species (ROS) and mucosal defensive factors that
include bicarbonate secretion, mucus-bicarbonate barrier, surface
active phospholipids, prostaglandins (PGs), mucosal blood ﬂow, cell
renewal and migration, non-enzymatic and enzymatic antioxidants
and some growth factors (Mota et al., 2009) leads to gastric damages.
The prevention or cure of peptic ulcers has become an important
challenge in the current medicine world. Although gastric ulcer is
linked to many causative factors, secretion of gastric acid is still
believed to remain as the central component of this disease (Mota
et al., 2009). Thus, inhibition of gastric acid secretion is the key
therapeutic target for ulcer diseases (Jain et al., 2007). Therefore,
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current medicinal treatment of gastric ulcers available is generally
based on the inhibition of gastric acid secretion by histamine
H2-antagonists, proton pump inhibitors, and antimuscarinics, as
well as on acid-independent therapy provided by sucralfate and
bismuth cholinergics (Bighetti et al., 2005). However, gastric ulcer
therapy faces a major drawback nowadays as most of the drugs
available in the market are often associated with side effects
(Bandyopadhyay et al., 2002; Rang et al., 2012).
In this context, the use of medicinal plants has gained interest
of many researchers. Natural product is in continuous expansion
all over the world and became the most attractive source of new
drug for the treatment and prevention of many diseases. Diverse
range of bioactive molecules isolated from plant natural product
have been shown to produce promising results for the treatment
of gastric ulcer (Borelli and Izzo, 2000).
One of the plants that is currently under investigation for its
potential pharmacological activities in our laboratory is Muntingia
calabura L. (family Muntingiaceae), commonly known as Jamaican
cherry or kerukup siam in Malaysia. Muntingia calabura is widely
cultivated in warm areas of Asian region, including Malaysia (Chin,
1989) and has become one of the most common roadside trees in
Malaysia. Several medicinal uses have been documented on various
parts of this tree in Asia and tropical America. Muntingia calabura’s
leaves, barks, ﬂowers, and roots have been used as a folk remedy to
treat incipient cold, fever, headaches, employed as an emmenagogue
and abortifacient, as well as an antiseptic, antispasmodic, and
antidyspeptic agent (Kaneda et al., 1991; Nshimo et al., 1993).
Scientiﬁc evaluations on Muntingia calabura have revealed
several pharmacological activities possessed by the plant. Muntin-
gia calabura leaves have been reported to exhibit signiﬁcant anti-
inﬂammatory, antipyretic (Zakaria et al., 2007c), antinociception
(Zakaria et al., 2006b, 2007b, 2007c), antitumor (Kaneda et al.,
1991; Su et al., 2003), antiproliferative, antioxidant (Zakaria et al.,
2011) and antibacterial (Zakaria et al., 2006a) activities. Flavo-
noids, saponins, tannins, triterpenes and steroids have been
detected in the leaves of Muntingia calabura (Zakaria et al.,
2007c). Several types of ﬂavonoids have been isolated and identi-
ﬁed from the leaves, roots and stem barks of Muntingia calabura
(Kaneda et al., 1991; Nshimo et al., 1993; Su et al., 2003; Chen
et al., 2005; Suﬁan et al., 2013). Recently, we have reported the
signiﬁcant antiulcer activity of methanol extract of Muntingia
calabura leaves and its modulation of endogenous nitric oxide
and non-protein sulfhydryl compounds (Balan et al., 2013). There-
fore, the present study was aimed to investigate the antiulcer
mechanisms of methanol extract of Muntingia calabura leaf
(MEMC) to provide a better understanding of the plant’s gastro-
protective effect.
2. Materials and methods
2.1. Plant material
Muntingia calabura leaves were collected from their natural
habitat in Shah Alam, Selangor, Malaysia, between May and August
2010. The plant was re-identiﬁed by a botanist from the Institute
of Bioscience (IBS), Universiti Putra Malaysia (UPM), Serdang,
Selangor, based on a voucher specimen (SK 964/04) deposited
earlier at the UPM IBS Laboratory of Natural Products Herbarium.
2.2. Preparation of methanol extract of Muntingia calabura
The preparation of MEMC was done according to Zakaria et al.
(2011). Matured leaves (500 g) were ground into ﬁne powder after
air-drying them at room temperature (2772 1C) for 1–2 weeks.
Methanol was used as the solvent. The powder was soaked in
methanol at a ratio of 1:20 (w/v) for 72 h. Filter funnel, cotton and
Whatman no. 1 ﬁlter paper were used to ﬁlter the mixture. The
soaking and ﬁltration were repeated on the residue for twice. The
ﬁltrate collected from each extraction was pooled and evaporated
in a rotary evaporator at 40 1C under reduced pressure.
2.3. Phytochemical screening and HPLC proﬁling
The phytochemical screening of MEMC was performed accord-
ing to the conventional protocols as adopted by Zakaria et al.
(2012). The HPLC proﬁle of MEMC was done according to Zakaria
et al. (2012) with slight modiﬁcations. Brieﬂy, 10 mg of crude dried
MEMC was dissolved in 1 ml methanol and ﬁltered through a
membrane ﬁlter with a pore size of 0.45 mm prior to analysis.
A HPLC system (Waters Delta 600 with 600 Controller) with a
photodiode array detector (waters 996) (Milford, MA, USA) was
used to run the proﬁling. A Phenomenex Luna (5 mm) (Torrance,
CA, USA) column was used (4.6 mm i.d.250 mm). Two solvents
denoted as A and B were used for elution of the constituents.
A was 0.1% aqueous formic acid and B was acetonitrile. Initial
conditions were 95% A and 5% B with a linear gradient reaching
25% B at t¼12 min. This was maintained for 10 min. At t ¼22 min,
B was reduced to 15%, which was then maintained until t¼30 min.
The programme returned to the initial solvent composition at
t¼35 min. The ﬂow rate used was 1.0 ml/min and the injection
volume was 10 ml. The column oven was set at 27 1C and the eluent
was monitored at 254, 300 and 366 nm. The retention time and
UV spectra of major peaks were analyzed. MEMC was then spiked
with a list of ﬂavonoid compounds, which served as the standard,
namely pinostrobin, hesperetin, ﬂavanone, 4ʹ,5,7-trihydroxy ﬂava-
none, 2,4,4ʹ-trihydroxy chalcone, quercitrin, dihydroquercetin,
ﬁsetin, quercetin, rutin, quercitrin, naringenin, silibinin, and gen-
istein using the same solvent system in order to determine the
presence of these constituents in the extract. The HPLC analysis
was carried out in the Laboratory of Phytomedicine, Medicinal
Plants Division, Forest Research Institute of Malaysia (FRIM),
Kepong, Malaysia.
2.4. Antioxidant activity of MEMC
2.4.1. Superoxide scavenging activity
The method of Chang et al. (1996) with slight modiﬁcation has
been employed to determine superoxide scavenging activity of
MEMC. Nitro-blue tetrazolium (NBT) solution (100 ml of 4.1 mM/l)
was prepared by adding 3.15 g Tris-HCl, 0.1 g MgCl2, 15.0 mg
5-bromo-4-chloro-3-indolyl phosphate and 34.0 mg 4-nitro-blue
tetrazolium chloride to 100 ml of distilled water. The reaction
mixture (100 ml) was prepared by dissolving 0.53 g sodium carbo-
nate (pH 10.2), 4.0 mg ethylene diamine tetraacetic acid (EDTA) and
500 mg xanthine in 0.025 mM NBT solution. The mixture was
refrigerated at 4 1C. The reaction mixture (999 ml) was transferred
into a microcuvette and placed in a 25 1C cell holder of spectro-
photometer. Superoxide generation was initiated by adding 1.0 ml of
xanthine oxidase (XOD) (20 U/ml). The optical density (OD) mea-
surements were taken at 560 nm for 120 s using Lambda 2S spectro-
photometer. MEMC was dissolved in the reaction mixture at the
concentration of 200 mg/ml. The stock solution (200 ml) was added to
799 ml of the reaction mixture and placed in a cell holder to autozero.
One microliter of XOD (20 U/ml) was then added, mixed thoroughly
and similarly measured for the XOD curves.
2.4.2. DPPH radical scavenging activity
Antioxidant reducing activity on DPPH radical was carried out
according to the method of Blois (1958) with modiﬁcation using
a high-throughput microplate system. Fifty microliter of sample
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(1.0 mg/mL) was added to 50 μL of DPPH (FG: 394.32) (1 mM in
ethanolic solution) and 150 μL of absolute ethanol in a 96-well
microtiter plate in triplicates. The plate was shaken for 15 s at
500 rpm and left to stand at room temperature for 30 min. The
absorbance of the resulting solution was measured spectrophoto-
metrically at 520 nm.
2.4.3. ORAC assay
The ORAC assay was performed as described by Huang et al.
(2002) with some modiﬁcations. 2,2ʹ-Azobis(2-methylpropiona-
midine) dihydrochloride (AAPH) (0.65 g) was dissolved in 10 ml of
75 mM phosphate buffer (pH 7.4) to a ﬁnal concentration of
240 mM (made fresh). A ﬂuorescein stock solution (1 mM) was
made in 75 mM phosphate buffer (pH 7.4) and stored, wrapped in
foil at 5 1C. Immediately prior to use, the stock solution was
diluted 1:100,000 with 75 mM phosphate buffer. The diluted
sodium ﬂuorescein was made fresh daily. The sodium ﬂuorescein
solution (150 ml) was added to the interior experimental wells. The
blanks received 25 ml of Trolox dilution. The sample wells received
25 ml samples. The plate was then allowed to equilibrate by
incubating for 10 min at 37 1C. BMG Omega Fluostar Fluorescent
Spectrophotometer with injector was used with an excitation ﬁlter
of 485 nm bandpass and emission ﬁlter of 528 nm bandpass. The
plate reader was controlled by MARS data analysis software.
Reactions were initiated by the addition of 25 ml of AAPH
solution (240 mM) using the microplate reader’s injector for a
ﬁnal reaction volume of 200 ml. The addition of 25 ml of AAPH
solution was followed by shaking at maximum intensity for 50 s.
The ﬂuorescence was then monitored kinetically with data taken
every minute. The ﬂuorescence of each well was measured by top
reading every 60 s. ORAC values were calculated using MARS Data
Analysis Reduction Software.
2.4.4. Total phenolic content
Determination of total phenolic content (TPC) was performed
using the Folin–Ciocalteu reagent according to the method of
Singleton and Rossi (1965) with slight modiﬁcations. One milli-
gram of MEMC was extracted for 2 h with 1.0 ml of 80% methanol
containing 1.0% hydrochloric acid and 1.0% of distilled water at
room temperature on the shaker set at 200 rpm. The mixture was
centrifuged at 6000 rpm for 15 min, and the supernatant trans-
ferred into vials. TPC was determined using the supernatant.
A 200 ml of supernatant extract was mixed with 400 ml of the
Folin–Ciocalteu reagent (0.1 mL/0.9 mL) and incubated at room
temperature for 5 min. This followed by the addition of 400 ml of
sodium bicarbonate (60.0 mg/ml) and the mixture was incubated
at room temperature for 90 min. Absorbance was measured at
725 nm. A calibration curve was generated by using the gallic acid
standard OD. The TPC levels found in the samples were expressed
as gallic acid equivalent (GAE)–TPC mg/100 g.
2.5. Animals
All experiments were performed on male Sprague Dawley rats
(180–200 g; 8–10 weeks old) obtained from the Animal Unit,
Faculty of Medicine and Health Sciences, UPM, Malaysia. The
animals were caged in polypropylene cages with wood shaving,
fed with standard pellet and allowed free access to water. They
were kept in room temperature (2772 1C; 70–80% humidity; 12 h
light/darkness cycle) in the Animal Holding Unit (UPM). The rats
were fasted prior to all assays, standard drugs and MEMC were
administered orally (p.o.) by gavage with 8% Tween 80 (10 ml/kg)
as the vehicle. The use of animals in the following study was
approved by the Animal Care and Used Committee (ACUC) of
Faculty of Medicine and Health Sciences, UPM (approval no. UPM/
FPSK/PADS/BR-UUH/00474).
2.6. Pharmacological assay
2.6.1. Pylorus ligation induced ulceration
Pylorus ligation was carried out according to the method by
Shay et al. (1945) with slight modiﬁcations. Thirty rats were
divided into ﬁve groups. Group-I (control) was treated with
vehicle (8% Tween 80), Group-II (positive control, ranitidine) was
given at 100 mg/kg (p.o), Group-III, -IV and-V rats were treated
with MEMC (100, 200 and 500 mg/kg, respectively). Pylorus
ligation was performed 1 h after the administration of the test
compounds on 48 h fasted rats. Under light anesthesia induced
using ketamine HCl (100 mg/kg, intramuscular) and xylazine HCl
(16 mg/kg, intramuscular), a 2 cm long incision was made in the
abdomen just below the sternum. The stomach was exposed, and a
thread was passed around the pyloric sphincter and tied in a tight
knot. Care was taken while tying the knot to avoid involving blood
vessels in the knot. The abdomen was sutured, and the skin was
cleaned of any blood spots or bleeding. The animals were sacri-
ﬁced 6 h after ligation by cervical dislocation. The stomachs were
removed, and the contents were drained out, collected, and
centrifuged. The stomach was opened along the greater curvature
to determine the lesion damage as described by Balan et al. (2013).
The percentage protection was calculated using the following
formula:
Protection ð%Þ ¼ ðUA control–UA pre treated groupÞðUA controlÞ  100%
2.6.2. Determination of volume, pH, free and total acidity of gastric
content
The drained gastric content was centrifuged at 2500 rpm for
10 min. The volume and pH of the gastric juice were measured and
were subjected to free and total acidity estimation. The method
described by Srivastava et al. (2010) was employed in free and
total acidity estimation. Free acidity was determined by titration
with 0.01 N NaOH with methyl orange reagent until the color of
the solution became yellowish. The volume of alkali added was
noted. Then, two to three drops of phenolphthalein was added and
the solution was titrated until a deﬁnite red tinge appear. The total
volume of NaOH added was noted and this corresponds to total
acidity. Acidity was calculated using the following formula:
Acidity¼ Volume of NaOH normality of NaOH 100
0:1
meq=l
2.6.3. Estimation of gastric wall mucus content
Gastric wall mucus content was determined by the method
described by Corne et al. (1974) with slight modiﬁcations. The
stomach was opened along the greater curvature, weighed, and
immersed in 10 ml of 0.1% Alcian Blue in 0.16 M sucrose/0.05 M
sodium acetate, pH 5.8 for 2 h. The excessive dye was then
removed by two successive rinses in 0.25 M sucrose solution
(15 min each). The remaining dye complexed with the gastric
mucus were extracted with 0.5 M MgCl2 for 2 h and shaken
intermittently for 1 min in every 30 min interval. The blue extract
was then shaken vigorously with an equal volume of diethyl ether
and the resulting emulsion was centrifuged at 3600 rpm for
10 min. The OD of Alcian Blue in the aqueous layer was read at
580 nm using a spectrophotometer. The quantity of Alcian Blue
extract per gramwet stomach was then calculated from a standard
curve.
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2.7. In vitro effect of MEMC on nitric oxide
2.7.1. Cell culture and stimulation
The murine monocytic macrophages’ cell line (RAW 264.7) was
purchased from European Collection of Cell Cultures (Porton
Down, UK) and maintained in DMEM supplemented with 10%
FBS, 4.5 g/L glucose, sodium pyruvate (1 mM), L-glutamine (2 mM),
streptomycin (50 μg/ml), and penicillin (50 U/ml) at 37 1C and
5% CO2. The cells (4105 cells/well) were seeded into a 96-well
plate and incubated in a CO2 incubator for 2 h at 37 1C to enable
the attachment of the cells. The attached cells in the well were
then triggered with stimuli (100 U/ml of IFN-g and 5 μg/ml of LPS)
with or without the presence of MEMC tested at concentration
ranging from 12.5 to 100 μg/ml. DMSO was used as a vehicle to
dissolve the MEMC. The ﬁnal concentration of DMSO was ensured
to be 0.1% in all cultures. Cells were then incubated at 37 1C in a
CO2 incubator for 17–20 h. The culture supernatant was subjected
to Griess assay for nitrite determination and the cells remaining in
the well were tested for cell viability assay.
2.7.2. Nitrite determination
Griess assay was used to determine the concentration of nitrite
(NO2), the stable metabolite of NO in culture medium, according
to Lee et al. (2011). An equal volume of Griess reagent was mixed
with culture supernatant. The color development was measured
using at 550 nm. The amount of nitrite in the culture supernatant
was calculated based on the standard curve of a sodium nitrite
freshly prepared in deionized water, concentration ranging from
0 to 100 μM. Percentage of the NO inhibition was calculated by
using the following formula:
NO inhibitory ð%Þ ¼ ½NO2
 controln–½NO2  sample
½NO2  controln
 100%
ncontrol is the nitrite level of IFN-γ/LPS-induced group.
2.7.3. Cell viability
The cytotoxicity of MEMC on the cultured cells was determined
by assaying the reduction of 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2 H-tetrazolium bromide (MTT) according to the method
described by Lee et al. (2011). The MTT reagents (0.05 mg/ml) were
dissolved in sterile PBS, pH 7.0. MTT reagents were added into each
well after removing the supernatant. The remaining cells were
incubated at 37 1C for 4 h. One hundred microliters of 100% DMSO
was then added into the wells to dissolve the formazan salts
formed. The absorbance was measured at 570 nm. The percentage
of cell viability was calculated according to the following formula,
where control is the cell viability of IFN-γ /LPS-induced group:
Cell viability ð%Þ ¼OD controlOD sample
OD control
 100%
2.8. In vitro anti-inﬂammatory effect of MEMC
2.8.1. Lipoxygenase assay
Lipoxygenase inhibiting activity was measured using spectro-
photometric method as described by Azhar-Ul-Haq et al. (2004).
Sodium phosphate buffer 160 ml (0.1 M, pH 8.0), 10 ml of MEMC and
20 ml of soybean lipoxygenase solution were mixed and incubated
for 10 min at 25 1C. An addition of 10 ml of the substrate in the
form of sodium linoleic acid solution will then initiate the reaction.
The enzymatic conversion of linoleic acid to form (9Z, 11E)-(13 S)-
13-hydroperoxyoctadeca-9,11-dienoate was followed by the
change of absorbance measured at 234 nm over period of 6 min.
MEMC and reference standards were dissolved in methanol. All
reactions were performed in triplicates in a 96-well microplate.
2.8.2. Xanthine oxidase assay
The spectrophotometric method from Noro et al. (1983) was
employed to measure the xanthine oxidase inhibiting activity of
MEMC. Potassium phosphate buffer 130 μl (0.05 M, pH 7.5), 10 μl
of the test solution and 10 μl of xanthine oxidase solution were
mixed and incubated for 10 min at 25 1C. The reaction was then
initiated by the addition of 100 μl of the substrate in the form of
xanthine solution. The enzymatic conversion of xanthine to form
uric acid and hydrogen peroxides measured at absorbance of
295 nm. MEMC and reference standards were dissolved in DMSO.
All reactions were performed in triplicates in a 96-well UV
microplate.
2.9. Statistical analysis
The results were expressed as mean7SEM and analyzed using
one way analysis of variance (ANOVA), followed by Dunnett’s post
hoc test. Results were considered signiﬁcant when po0.05.
3. Results
3.1. Phytochemical screening
Phytochemical investigation on the crude extract revealed the
presence of various compounds, such as ﬂavonoids, tannins,
polyphenols, saponins and steroids and the absence of triterpenes
and alkaloids. On the other hand, the Muntingia calabura leaves
powder was found to contain ﬂavonoids, tannins, polyphenols,
saponins, steroids and triterpenes, but not alkaloids (Table 1).
3.2. HPLC proﬁling
The HPLC analysis of MEMC was measured at three different
wavelengths, 254, 330, and 366 nm, and the best separation was
obtained at two wavelengths, which were 254 and 366 nm
(Fig. 1A). Ten major peaks were separated at these wavelengths,
which were P1 (RT¼2.846 min), P2 (RT¼3.998 min), P3 (RT¼
14.584 min), P4 (RT¼19.008 min), P5 (RT¼19.456 min), P6
(RT¼21.096 min), P7 (RT¼20.349 min), P8 (RT¼22.546 min), P9
(RT¼23.234 min) and P10 (RT¼27.805 min). Further analysis
demonstrated that these 10 peaks showed λmax values in the
region of 222.5–274.4, 221.3–272.0, 219.0–272.0, 219.0–278.0,
207.2–361.3, 254.3–367.2, 207.2–351.7, 207.2–343.4, 207.2–349.4
and 204.9–366.3 nm, respectively (Fig. 1B), suggesting, in part, the
presence of ﬂavonoid-based compounds. Comparison between
chromatogram of the standard compounds with chromatogram
of MEMC revealed the presence of rutin, ﬁsetin, quercitrin and
dihydroquercetin (Fig. 1C) as spiking of these compounds in MEMC
increases the peak area.
Table 1
Comparison on the phytochemical constituents of the leaves and methanol extract
of Muntingia calabura (MEMC).
Phytochemical constituent Muntingia calabura powder MEMC
Flavonoids þþþ þ
Tannins and polyphenols þþ þþ
Triterpenes þþ –
Saponins þ þþ
Alkaloids – –
Steroids þþþ þ
For ﬂavonoids, tannins, triterpenes, and steroids: þ , weak color; þþ , mild color;
þþþ , strong color.
For saponins: þ , 1–2 cm froth; þþ , 2–3 cm froth; þþþ , 43 cm froth.
For alkaloids: þ , negligible amount of precipitate; þþ , weak precipitate; þþþ ,
strong precipitate.
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Fig. 1. (A) The HPLC proﬁle of MEMC at the wavelengths of 254 and 366 nm. (B) The UV spectra analysis of MEMC. The UV spoectra demonstrated the presence of 10 major
peaks labeled as P1 (RT¼2.846 min), P2 (RT¼3.998 min), P3 (RT¼14.584 min), P4 (RT¼19.008 min), P5 (RT¼19.456 min), P6 (RT¼21.096 min), P7 (RT¼20.349 min), P8
(RT¼22.546 min), P9 (RT¼23.234 min) and P10 (RT¼27.805 min), which were observed at their respective λmax at the region of 222.5–274.4, 221.3–272.0, 219.0–272.0,
219.0–278.0, 207.2–361.3, 254.3–367.2, 207.2–351.7, 207.2–343.4, 207.2–349.4 and 204.9–366.3 nm, respectively, suggesting, in part the presence of ﬂavonoid-based
compounds. (C) Comparison between chromatogram of the standard compounds, namely rutin, quercitrin, ﬁsetin and dihydroquercetin with chromatogram of MEMC at
366 nm showing the presence of rutin, quercitrin, ﬁsetin and dihydroquercetin in MEMC.
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3.3. Antioxidant assays
The antioxidant activities of the Muntingia calabura were
investigated by superoxide scavenging, DPPH radical scavenging,
and ORAC assays. At the concentration of 200 μg/ml, MEMC
produced high superoxide and DPPH scavenging activity
(Table 2). ORAC assay was used to evaluate the total antioxidant
capacity of Muntingia calabura. The ORAC value was based on the
net area under the curve (AUC) of ﬂuorescent decay curve for
various concentrations of MEMC and the values have been
expressed as relative Trolox equivalents (TE) (Table 2). On the
other hand, evaluation of the total phenolic content showed a high
value indicating the high level of phenolic present in the MEMC
(Table 2).
3.4. Gastroprotective study
3.4.1. Pylorus ligation-induced gastric lesion
Gastric lesion measurements of pylorus-ligated rats showed
that MEMC signiﬁcantly decreased the ulcer area at the doses of
100, 250, and 500 mg/kg. Ranitidine (100 mg/kg), the standard
drug used as the positive control in the study, also showed
signiﬁcant reduction of gastric lesion. The ulcer inhibition was
found to be 77.6, 79.3, and 77.6%, respectively, while ranitidine
showed 87.9% protection in comparison to the control group
(Fig. 2).
3.4.2. Evaluation of gastric juice parameters
The effects of MEMC upon baseline acid secretion acid collected
after 6 h of pylorus ligature in rats are shown in Table 3. MEMC, at
all the three doses (100, 250, and 500 mg/kg) signiﬁcantly decreased
the volume of gastric secretion by 62% (p o0.01), 72% (p o0.001)
and 71% (p o0.001), respectively. As for the pH of the gastric
juice, all the doses of MEMC showed an increment in the pH value
but the values were not signiﬁcantly different as compared to the
negative control. Meanwhile, the free acidity of MEMC was also
found to be not signiﬁcantly different. However, the total acidity was
signiﬁcantly reduced in the doses of 100 and 500 mg/kg of MEMC by
about 25% (p o0.05) and 36% (p o0.001), respectively, while
250 mg/kg of MEMC failed to signiﬁcantly decrease the total acidity
of the gastric secretion. Ranitidine (100 mg/kg) caused a reduction
in the volume of secretion by 83% (po0.001), increased the pH
by about 2.2 folds (po0.001) and decreased the total acidity of
the gastric juice by about 41% (po0.001) as compared to the
control group.
3.4.3. Determination of mucus in the gastric mucosa
As observed in Fig. 3, pre-treatment with MEMC caused a
signiﬁcant increment in gastric wall mucus content in all the doses
administered (100, 250, and 500 mg/kg) whereby the amount of
mucus recorded was signiﬁcantly higher (p o0.01) when com-
pared with the control animals pretreated with vehicle alone. The
rats that received ranitidine also increased the mucus content
signiﬁcantly (p o0.001).
3.5. In vitro effect of NO
The RAW 264.7 cells were induced into an inﬂammatory state
by treatment with LPS/IFN-γ causing synthesis and secretion of
excessive NO. Nitrite ions (NO2), which is the stable metabolite of
NO, was detected in the induced culture medium at a mean
concentration of 49.65 μM. Trace amount of NO was found in
the cells that were not induced. MEMC at the highest concentra-
tion tested (100 mg/ml) produced signiﬁcant (po0.05) inhibitory
activity (Fig. 4), upon IFN-g/LPS treated macrophages. At the lower
concentration of MEMC (50, 25, and 12.5 mg/ml), NO was not
signiﬁcantly inhibited (Fig. 4). L-NAME, a standard NOS inhibitor,
used as a positive control in the assay, caused a signiﬁcant
inhibition of NO (po0.05).
3.6. Cytotoxicity of MEMC
MTT assay was conducted to determine the cytotoxicity of the
tested extract on the viability of RAW 264.7 cells. In this study, the
viability of RAW 264.7 cells upon treatment of MEMC was high for
the concentration of 100, 50, 25, and 12.5 mg/ml (Fig. 4). The result
showed that the extract did not cause toxicity to the cells and the
NO suppressive action of the extract at the highest concentration
was not due to the cytotoxicity effect.
Table 2
The antioxidant activity and TPC value of MEMC determined using various assays.
Samples Superoxide scavenging (%) DPPH (%) ORAC (lM TE/100 g) Total phenolic content (TPC)
mg/100 g GAE
Sample concentration (lg/ml) 200 200 200 200
Standard Superoxide dismutase (SOD) (610–3 U/ml) Ascorbic acid (AA) 200 mg/ml Trolox standard curve Gallic acid (GAE) standard curve
MEMC 99.3270.18 (H) 98.6870.38 (H) 24,955.0071495.23 2751.26710.51 (H)
All values are expressed as mean7SEM.
Superoxide scavenging and DPPH radical scavenging: H, high (70–100%); M, moderate (50–69%); L, low (0–49%).
TPC 1. TPC value 41000 mg GAE/100 g is considered high total phenolic content.
TPC 2. TPC expressed as milligram equivalent to gallic acid per 100 g of dry weight (mg GAE/100 g).
ORAC value expressed as mM trolox equivalent (TE)/100 g is mean values from triplicate wells in duplicate experiments, with SEMo20%.
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Fig. 2. Effect of oral administration of vehicle (Tween 80, 8%), ranitidine (100 mg/kg)
or MEMC (100, 250, and 500 mg/kg) on pylorus ligation-induced ulcer. The ulcerated
area (mm2) was expressed as mean7SEM for six animals. One way ANOVA was
followed by Dunnett’s post hoc test, ***po0.001 vs. vehicle.
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3.7. Effects of plant extract on anti-inﬂammatory mediators
MEMC exhibited high anti-inﬂammatory properties in the
two assays tested, namely the lipoxygenase and xanthine oxidase
assays. The ﬁnal concentration of the sample was 100 mg/ml. In the
lipoxygenase assay, the result exhibited a high inhibition of
enzyme activity. Meanwhile, when tested using the xanthine
oxidase assay, the extract showed moderate inhibition (Table 4).
4. Discussion
The present study aimed to investigate the antiulcer mechan-
ism(s) of MEMC. In our previous study, pharmacological evaluation
of MEMC revealed that this extract was effective in inhibiting
ulcers caused by ethanol and indomethacin (Balan et al., 2013).
Meanwhile, in the current study, MEMC administration showed
a signiﬁcant protection against ulcers induced by pylorus ligation.
This is one of the most widely used models to study the effect of
drugs on gastric acid and mucus secretion. Ulcers developed by
ligating the pyloric end of the stomach are caused by an increase
in gastric hydrochloric acid (HCl) secretion and/or stasis of acid,
leading to auto digestion of the gastric mucosa and breakdown of
the gastric mucosal barrier (Kumar et al., 2011).
Parietal or oxyntic cells are the principle cell in gastric glands,
which secrete gastric acid (HCl) to promote proteolytic digestion of
foodstuffs, iron absorption, and killing pathogens (Rang et al.,
2012). The three most important mediators, namely acetylcholine,
gastrin, and histamine, interact with speciﬁc receptors located at
the basolateral membrane of the parietal cells that stimulate
gastric acid secretion (Oiry et al., 1999). The regulation of gastric
acid secretion by the parietal cells is an important factor in the
pathogenesis of peptic ulcer. Therefore, the inhibition of gastric
acid secretion is a key therapeutic target for the ulcer diseases
(Jain et al., 2007). Our ﬁndings in this study clearly demonstrated
that MEMC inhibited the aggressive factor by signiﬁcantly redu-
cing the volume of gastric secretion and total acidity in the rats.
This may possibly be due to the anti-secretory property of MEMC.
Gastric mucus plays an important role in the gastric ulcer
defense mechanism, whereby it forms a continuous mucus gel-like
protective barrier coating the entire gastric mucosa that maintains
the mucosal surface at a pH of 6–7 in the acidic environment
(pH 1–2). In gastric ulcers, in spite of low acid secretion, weaken-
ing of mucosal defenses can also lead to severe injury (Jain et al.,
2007). The important criteria that determine the status of mucosal
defense barrier against the unpleasant attack of acid and pepsin
are the quality and quantity of gastric mucus secretion (Rachchh
and Jain, 2008). According to Venables (1986), rise in amount of
mucus secreted by the gastric mucosal cells prevent ulcer forma-
tion by acting as an effective barrier to the back diffusion of
hydrogen ions, improving the buffering of gastric acid juice and
reducing stomach wall friction during peristalsis. The mucus
comprises of mucin-type glycoproteins that can be detected by
amounts of Alcian Blue binding (Corne et al., 1974). Our present
study revealed that administration of MEMC was able to increase
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Fig. 3. Effect of oral administration of vehicle (Tween 80, 8%), ranitidine (100 mg/kg)
or MEMC (100, 250 and 500 mg/kg) on gastric wall mucus produced in the stomach.
The gastric wall mucus content (mg Alcian Blue/g wet tissue) was expressed as
mean7SEM for six animals. One way ANOVAwas followed by Dunnett’s post hoc test,
***po0.001, **po0.01 vs. vehicle.
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Fig. 4. Effect of MEMC tested against nitric oxide (NO) production and RAW
264.7 cell viability. The assays were done in triplicate. One way ANOVA was
followed by Dunnett’s post hoc test, *po0.05 shows signiﬁcant difference as
compared to the IFN-γ/LPS-treated group (inﬂammation induced group).
Table 4
Effect of MEMC on the anti-inﬂammatory mediators using the
in vitro lipoxygenase and xantine oxidase assays.
Sample MEMC
Concentration (mg/ml) 100
Lipoxygenase (%) 87.6574.21 (H)
Xantine oxidase (%) 51.8974.58 (M)
All values are expressed as mean7SEM.
Note: H, high (71–100%); M, moderate (41–70%); L, low (0–40%);
NA, not active.
Table 3
Effect of MEMC on several gastric content parameters in pylorus-ligated rat model.
Treatment Volume of gastric juice (ml) pH Free acidity (mEq/l) Total acidity (mEq/l)
Control (8% Tween 80) 6.1771.20 1.2570.04 70.0077.86 131.8379.01
Ranitidine 1.0370.22*** 2.7770.31*** 54.8374.93 77.6774.85***
MEMC
100 mg/kg 2.3570.62** 1.6170.17 60.33710.18 99.5075.61*
250 mg/kg 1.6870.49*** 1.8270.19 60.8379.92 121.0077.80
500 mg/kg 1.6070.50*** 2.0370.32 45.8377.32 84.8378.45***
Values are expressed as mean7SEM for six animals in each group. One way ANOVA was followed by Dunnett’s post hoc test.
n po0.05 as compared to the control group within the respective column.
nn po0.01 as compared to the control group within the respective column.
nnn po0.001 as compared to the control group within the respective column.
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the amount of mucus secretion, supporting the point that one of
the potential mechanisms of the gastroprotective effect elicited by
MEMC is a result from enhancement of the gastric mucosal
defense action.
Overall, treatment of MEMC appears to signiﬁcantly weaken
the gastric aggressive factors by decreasing the amount of gastric
secretion and total acidity while enhancing the cytoprotective
factor by strengthening the gastric mucosal barrier. This explains
the antiulcer effect of MEMC in the pylorus ligation induced ulcer
model, whereby MEMC was able to exert signiﬁcant protection as
compared to the control group. The positive control used was
ranitidine, which also revealed signiﬁcant gastroprotective effect.
On the other hand, our ﬁndings also showed that there was an
increase in the pH and free acidity of the gastric secretion, but not
signiﬁcantly higher as compared to the control group.
Other than the imbalance between the aggressive and defen-
sive factors, increase in free radicals and oxidative processes also
strongly contributes to the ulcer disease. For this reason, it is
hypothesized that the ability of an extract/compound to scavenge
free radicals and elicit antioxidant properties could also be one of
the pathways in which the extract exerts its protective effect.
Pathogenesis of gastric ulcer involves oxidative stress with anti-
oxidants plays a very important role in order to protect gastric
mucosa (Trivedi and Rawal, 2001) and repairing gastric damage. In
our in vitro experiment, MEMC inhibited superoxide and DPPH
radical activity effectively. Thus, it can be postulated that MEMC
exhibited high antioxidant activity in both the pathways. On the
other hand, ORAC is a classic tool for measuring the antioxidant
capacity of natural products (Prior et al., 2007). This assay was
used to measure the peroxyl radical absorbing capacity of the
extract. The ORAC method is unique in its analysis as it takes into
account the inhibition time and degree of inhibition into a single
quantity by measuring the area under the curve (Mukherjee et al.,
2010). Our ﬁndings demonstrated that MEMC exhibited high ORAC
value indicating a potent antioxidant activity of the extract.
In addition, the chemical analysis revealed that the MEMC has
high total phenolic content, which explains the high antioxidant
activity of MEMC exhibited in various antioxidant pathways.
The inﬂammatory processes are thought to be responsible for
producing various mediators, which are involved in the production
of reactive oxygen species (ROS) and NO that contribute to the
pathogenesis of ulcer disease. Nitric oxide is a ubiquitous mediator
and plays an important role as an endogenous modulator of
numerous physiological functions. In the gastrointestinal tract
(GIT), NO participates in the modulation of the smooth musculature
tone, such as the regulation of intestinal peristaltism, gastric empty-
ing, and antral motor activity (Martín et al., 2001). It also helps in
maintaining the gastric mucosal blood ﬂow, barrier function, alkaline
production, and regulates gastric mucus and acid secretion
(Calatayud et al., 2001). In physiological conditions, NO modulates
both the integrity and repairing of the tissues (Martín et al., 2001).
However, overproduction of NO by the inducible isoforms associated
with the tissue injury in the gut during inﬂammatory reactions
including peptic ulcer, chronic gastritis, gastrointestinal cancer,
bacterial gastroenteritis, celiac or chronic inﬂammatory bowel dis-
eases (Barrachina et al., 2001). This shows the double-edged role
played by NO in gastrointestinal ulcerative and inﬂammatory dis-
eases, whereby Barrachina et al. (2001) have reviewed in detail the
dual role of nitric oxide in modulating gastrointestinal mucosal
defense and injury. Our present study demonstrated signiﬁcant
inhibition of NO by MEMC upon inﬂammation induced macrophages
at its highest concentration, 100 mg/ml, as compared to the positive
control group. In contrary, our previous study reported the partici-
pation of NO in the gastroprotection exhibited by MEMC (Balan et al.,
2013). Therefore, it can be postulated that MEMC exhibited its
gastroprotective activity via modulation of NO.
Besides that, MEMC was also tested for its ability to inhibit
xanthine oxidase (XO). XO is an enzyme that generates ROS from
the chemical reaction it catalyzes. ROS react with cellular lipids,
causing the formation of lipid peroxides, which are metabolized
to malondialdehyde, a major product of lipid peroxidation
(Abdelwahab et al., 2013). ROS is an important pathogenic method
for gastric mucosal injury associated with ethanol consumption
(Smith et al., 1996). Huh et al. (1996) also reported that alcohol-
induced gastric mucosal damage may be, in part, due to the
increased activity of xanthine oxidase and type conversion rate
of the enzyme, leading to oxidative stress. An endogenous anti-
oxidant defense mechanism may constantly remove the contin-
uous production of ROS during normal metabolism (Lemos et al.,
2012). Thus, the moderate inhibition of xanthine oxidase exerted
by MEMC in our ﬁnding may contribute to its antiulcerative effect
via its antioxidant, especially the radical scavenging property as
reported earlier in this study.
Besides xanthine oxidase, MEMC exhibited high inhibition of
lipoxygenase (LOX) enzyme, in vitro. LOX are involved in the
metabolism of leukotrienes (LTs), which make it a likely target for
biochemical manipulation (Rask-Madsen et al., 1992). The LTs
possess potent inﬂammatory actions that could contribute in the
pathogenesis of gastric damage and disturbs the gastric mucosal
integrity. According to Boughton-Smith (1989), acute gastric
damage caused by ethanol showed a marked increase in the
mucosal formation of LTC4 and LTB4, whereby LTC4 causes
vasoconstriction in the gastric mucosa. LOX inhibitors are used
in the treatment of inﬂammatory bowel disease (IBD) as there is
an increased generation of LTs in the inﬂamed mucosa (Rask-
Madsen et al., 1992). Therefore, it can be postulated that LOX
partially mediate the production of gastric mucosal lesions
induced by damaging agents. The high LOX inhibition exerted by
MEMC could partially contribute to the gastroprotective activity of
the plant extract.
Phytochemical screening of MEMC revealed the presence of
ﬂavonoids, saponins, steroids, condensed tannins and polyphe-
nols. Su et al. (2003) and Chen et al. (2005) showed that
ﬂavonoids, such as pinocembrin, pinobanksin, pinostrobin, chrysin,
isoliquiritigenin and gnaphaliin, are present in the leaves of
Muntingia calabura. Flavonoids have been reported to act in the
gastrointestinal tract, exhibiting antispasmodic (Lima et al., 2005),
anti-secretory, antidiarrhoeal (Di Carlo et al., 1993) and antiulcer
properties (La Casa et al., 2000). Flavonoids were also reported to
exhibit antioxidant (Tapas et al., 2008; Ferreira et al., 2010) and
anti-inﬂammatory (Sandhar et al., 2011) activities. Flavonoids are
able to activate the mucosal defense system through stimulation of
gastric mucus secretion and scavenge for the ROS and free radicals
produced by ethanol (Abdelwahab et al., 2011). In addition, ﬂavo-
noids able to decrease ulcerogenic lesions by promoting the
formation of gastric mucosa inhibit the production of pepsinogen
and diminish acid mucosal secretion (La Casa et al., 2000). Mota
et al. (2009) have summarized the literature on 95 ﬂavonoids with
varying degrees of antiulcerogenic activity, conﬁrming that ﬂavo-
noids have a therapeutic potential for the more effective treatment
of peptic ulcers. On the other hand, tannins are known to “tan” the
outer most layer of the mucosa and to render it less permeable and
more resistant to chemical and mechanical injury or irritation
(Asuzu and Onu, 1990). Tannins form a protective pellicle by
promoting precipitation of protein on the ulcer in order to prevent
ulcer development. This pellicle helps in preventing toxic substance
absorption and combat the attack of proteolytic enzymes (John and
Onabanjo, 1990; Nwafor et al., 1996). Furthermore, the saponins
may exert its protective activities in ulceration by the activation of
mucous membrane protective factors (Choudhary et al., 2013).
Considering all these reports on different substances found in
MEMC, it is plausible to suggest that the gastroprotective activity
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of MEMC involved, partly, synergistic action of ﬂavonoids, con-
densed tannins, and saponins.
Our HPLC proﬁling of MEMC also showed the presence of
ﬂavonoid-based compounds. According to Tsimogiannis et al.
(2007) ﬂavonoids are divided into ﬁve major subgroups, namely
ﬂavones, ﬂavonols, ﬂavanonols, ﬂavanones and dihydroﬂavonols.
The UV–vis spectra of ﬂavonoids falls within two absorbance
bands called Band A and Band B. Band A, which represents
ﬂavones or ﬂavonols, lies in the range of 310–350 nm or 350–
385, respectively, while Band B falls between 250 and 290 nm,
resembling much the same in all the aforementioned ﬂavonoid
subgroups. Thus, the presence of ﬂavonoids detected in the extract
is in consistent with the ﬁnding obtained from the HPLC proﬁling.
Furthermore, MEMC, when spiked together with a list of
ﬂavonoids, the chromatogram analysis revealed the possible pre-
sence of rutin, dihydroquercetin, ﬁsetin and quercitrin. Rutin and
quercetin had been reported to prevent gastric mucosal ulceration
in several animal models (Barnaulov et al., 1982, 1983, 1985; Martin
et al., 1993; Alarcón de la Lastra et al., 1994; Izzo et al., 1994; Martin
et al., 1998; La Casa et al., 2000; Kahraman et al., 2003; Rao et al.,
2003). Izzo et al. (1994) reported that the protective effect of rutin
was mediated by endogenous platelet-activating factor (PAF)
whereas La Casa et al. (2000) said that the compound’s antioxidant
properties may be another possible mechanism underlying the
antiulcer effect of rutin. A latest study revealed that rutin exerts
antiulcer effect by inhibiting the gastric proton pump (Dubey et al.,
2013). On the other hand, quercetin’s mechanism of action involves
an increase in mucus production (Alarcón de la Lastra et al., 1994),
endogenous PAF (Izzo et al., 1994), antihistaminic properties,
inhibition of Helicobacter pylori (Beil et al., 1995), and its antioxidant
properties (Martin et al., 1998; Kahraman et al., 2003). Quercetin
was also reported to promote gastric healing (Motilva et al., 1992).
Barnaulov et al. (1982) demonstrated the antiulcer effect of querci-
trin in reserpin-induced ulceration whereas Kandhare et al. (2011)
reported the therapeutic value of ﬁsetin in the prevention of
experimental gastric ulcer by virtue of its antioxidant mechanism.
In conclusion, our ﬁndings from the present study showed that
MEMC exerts its gastroprotective effects via various mechanism(s).
The ability of MEMC to reduce gastric secretion and total acidity
while increase mucus production suggests the balanced protection
of MEMC against the aggressive and defensive factors of gastric
ulcer. Furthermore, the modulation of NO and inhibition of
lipoxygenase, xanthine oxidase and high radical scavenging activ-
ity show the mechanisms underlying the gastroprotective effect of
MEMC. High phenolic content and presence of phytochemicals
such as ﬂavonoids, tannins and saponins explain the effectiveness
of the extract in protecting against gastric damages. Further
studies are in progress to identify the bioactive compound
(s) that may be present, which could be responsible for the
antiulcer properties of Muntingia calabura.
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